Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

Authors of this article:

Zheyi Dong^{1, 2, 3, 4, 5} ;   Jianhui Zhou^{1, 2, 3, 4, 5} ;   Zhonggao Xu⁶ ;   Zhaohui Ni⁷ ;   Yani He⁸ ;   Hongli Lin^{9, 10} ;   Gengru Jiang¹¹ ;   Xuefeng Sun^{1, 2, 3, 4, 5} ;   Li Zhang^{1, 2, 3, 4, 5} ;   Xiangmei Chen^{1, 2, 3, 4, 5}